[1] Nadhan R, Vaman JV, C N, et al. Insights into dovetailing GTD and Cancers[J]. Crit Rev Oncol Hematol, 2017, 114: 77-90. [2] Shaaban AM, Rezvani M, Haroun RR, et al.Gestational Trophoblastic Disease: Clinical and Imaging Features[J]. Radiographics, 2017, 37(2): 681-700. [3] 张友胜,宁正祥,胡闫勇.黄酮类化合物二氢杨梅素的研究利用现状[J].中成药,2002,24(12):970-972. [4] Sun Y, Wang C, Meng Q, et al.Targeting P-glycoprotein and SORCIN: Dihydromyricetin strengthens anti-proliferative efficiency of adriamycin via MAPK/ERK and Ca2+-mediated apoptosis pathways in MCF-7/ADR and K562/ADR[J]. J Cell Physiol, 2018, 233(4): 3066-3079. [5] Lu CJ, He YF, Yuan WZ, et al.Dihydromyricetin-mediated inhibition of the Notch1 pathway induces apoptosis in QGY7701 and HepG2 hepatoma cells[J]. World J Gastroenterol, 2017, 23(34):6242-6251. [6] 周防震,张晓元,詹远京,等.二氢杨梅素抑制人乳腺癌细胞侵袭和下调MMP-2/-9蛋白表达研究[J].生物化学与生物物理进展,2012,39(4):352-358. [7] 高钟禹,俞孝庭.妊娠绒毛膜癌的起源[J].国外医学肿瘤学分册,1987,(3):129-133. [8] 谢幸. 妊娠滋养细胞疾病[J].现代妇产科进展,2006,15(4):241-256. [9] Librach CL, Werb Z, Fitzgerald ML, et al.92-kD type IV collagenase mediates invasion of human cytotrophoblasts[J]. J Cell Biol, 1991, 113(2): 437-449. [10] Staun-Ram E, Goldman S, Gabarin D, et al.Expression and importance of matrix metalloproteinase 2 and 9 (MMP-2 and -9) in human trophoblast invasion[J]. Reprod Biol Endocrinol, 2004, 2:59. [11] 向阳,赵峻.妊娠滋养细胞疾病诊治进展[J].中国实用妇科与产科杂志,2017,33(1):14-18. [12] Zheng W, Li J, Wang X, et al.Effects of Antarctic krill docosahe-xaenoic acid on MCF-7 cell migration and invasion induced by the interaction of CD95 with caveolin-1[J]. Life Sci, 2018, 192: 270-277. [13] Park GB, Chung YH, Kim D.Induction of galectin-1 by TLR-dependent PI3K activation enhances epithelial-mesenchymal transition of metastatic ovarian cancer cells[J]. Oncol Rep, 2017, 37(5): 3137-3145. [14] 王亚欣,张慧娟,刘媛,等.PI3K/PKB信号激活在妊娠滋养细胞疾病发病机制中的作用[J].现代妇产科进展,2015,24(1):22-29. [15] Wang R, Wang W, Ao L, et al.Benzo[a]pyrene-7,8-diol-9,10-epoxide suppresses the migration and invasion of human extravillous trophoblast HTR-8/SVneo cells by down-regulating MMP2 through inhibition of FAK/SRC/PI3K/AKT pathway[J]. Toxicology, 2017, 386: 72-83. |